Cleveland Clinic is partnering with the Novo Nordisk Foundation, a Denmark company focused on medical treatment and research, to launch the Cleveland Clinic – Denmark: Quantum-AI Biomedical Frontiers Fellowship Program.
Under the program, the Novo Nordisk Foundation will award up to $6.2 million over the next three years to facilitate the exchange of 12 researchers, according to an Aug. 5 news release from Cleveland Clinic.
Each researcher will receive a three-year term to conduct advanced research at either Cleveland Clinic or in Denmark. In Cleveland, the fellows will also have the chance to collaborate with IBM researchers through Cleveland Clinic’s Discovery Accelerator partnership.
The program will work to harness quantum technologies and AI to focus on scientific areas such as enhanced diagnostic precision, innovative drug discovery, optimization of clinical trials, and personalized medicine development.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
